Biocordis Pharmaceuticals Private Limited
About Biocordis Pharmaceuticals Private Limited
Data last updated:
Biocordis Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2011PTC033230. Its GSTIN is 04AAECB9222E1Z3 (Chandigarh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Anurag Bhatia and Karam Singh Babra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 259 1st Floor Motor Market Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹97.53 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹2.15 Lakh (net margin -2.2%) and EBITDA of ₹50,549 (EBITDA margin 0.5%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 1% over five years.
The company is associated with 1 brand: Biocordis Pharmaceuticals. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Biocordis Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address is in the company report.
- Email
- Registered AddressScf 259 1st Floor Motor Market Manimajra, Chandigarh, India – 160101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Biocordis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Biocordis Pharmaceuticals operates one associated brand: Biocordis Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of generic tablets, capsules, syrups, and injectables | biocordispharma.com |
Business activity
The main business activity of Biocordis Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Biocordis Pharmaceuticals Private Limited, buy the company report.
Financials of Biocordis Pharmaceuticals Private Limited
FY 2025 filings availableBiocordis Pharmaceuticals Private Limited reported revenue of ₹97.53 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA fell 89% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹50,549 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | -2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biocordis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Biocordis Pharmaceuticals Private Limited
Biocordis Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anurag Bhatia Also directs: Biocell Pharmaceuticals Private Limited | Director | 06 Sep 2011 | 15 Years 1 Months | Current |
| Karam Singh Babra | Director | 06 Sep 2011 | 15 Years 1 Months | Current |
| Deepika Bhatia Also directs: Biocell Pharmaceuticals Private Limited | Director | 07 Feb 2025 | 1 Years 8 Months | Current |
Auditor
Biocordis Pharmaceuticals Private Limited is audited by VISHAL CHITKARA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VISHAL CHITKARA & ASSOCIATES | FY 2021 | 012301N |
Shareholding
The shareholding of Biocordis Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Biocordis Pharmaceuticals Private Limited, buy the company report.
Legal cases
Biocordis Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by Wallace Pharmaceuticals Pvt Ltd | Pending |
| Bombay High Court | Court case (CRR) | Filed against the company by Wallace Pharmaceuticals Pvt Ltd | Pending |
To see the full case history of Biocordis Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biocordis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biocordis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAECB9222E1Z3 | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Biocordis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Biocordis Pharmaceuticals Private Limited has 4 board changes on record since 2011: 3 appointments and 1 cessation. The latest: Bharat Bhushan Singh ceased to be Director on 24 Feb 2025.
Frequently asked questions
Biocordis Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 September 2011 (15+ years old) and is registered under CIN U24232CH2011PTC033230.
Biocordis Pharmaceuticals has 3 current directors:
- Anurag Bhatia - Director
- Karam Singh Babra - Director
- Deepika Bhatia - Director
The latest financial statements of Biocordis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Biocordis Pharmaceuticals is 04AAECB9222E1Z3, registered in Chandigarh.
The CIN (Corporate Identification Number) of Biocordis Pharmaceuticals is U24232CH2011PTC033230. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biocordis Pharmaceuticals has 2 court cases on record: 2 filed against it. 2 are pending.
Biocordis Pharmaceuticals was incorporated on 06 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chandigarh.
Bharat Bhushan Singh ceased to be Director on 24 Feb 2025. Deepika Bhatia was appointed as Director on 07 Feb 2025. Anurag Bhatia was appointed as Director on 06 Sep 2011. Biocordis Pharmaceuticals has 4 board changes on record in total.
The registered office of Biocordis Pharmaceuticals is at Scf 259 1st Floor Motor Market Manimajra, Chandigarh, India – 160101.
Biocordis Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.